Seshadri Neervannan's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 2,605 Common Stock done at an average price of $46.3 . Disclosure was reported to the exchange on March 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.29 per share. | 18 Mar 2025 | 2,605 | 84,660 | - | 46.3 | 120,585 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 47.40 per share. | 18 Mar 2025 | 2,543 | 82,117 | - | 47.4 | 120,538 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.11 per share. | 18 Mar 2025 | 2,435 | 79,682 | - | 50.1 | 122,018 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 21,264 | 87,265 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 8,148 | 16,296 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 8,019 | 24,060 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 5,097 | 5,097 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 30,628 | 30,628 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 20,089 | 20,089 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,245 | 69,646 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 8,148 | 24,444 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 5,097 | 10,194 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.60 per share. | 15 Mar 2024 | 4,879 | 64,767 | - | 30.6 | 149,297 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 47,500 | 47,500 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 32,079 | 32,079 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.15 per share. | 21 Mar 2023 | 390 | 54,696 | - | 12.2 | 4,739 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 21 Mar 2023 | 379 | 55,086 | - | 12.6 | 4,791 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 21 Mar 2023 | 372 | 55,465 | - | 12.9 | 4,795 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 17 Mar 2023 | 380 | 55,837 | - | 12.6 | 4,792 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 17 Mar 2023 | 360 | 56,217 | - | 13.3 | 4,781 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 5,097 | 15,291 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 5,097 | 56,934 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 15 Mar 2023 | 357 | 56,577 | - | 13.4 | 4,795 | Common Stock |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 48,116 | 48,116 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 32,592 | 32,592 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 69,498 | 69,498 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 20,388 | 20,388 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Seshadri Neervannan | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 61,499 | 61,499 | - | - | Stock Option (right to buy) |